1 | 1 | Real-time fMRI for the Treatment of Aggressive Behavior in Adolescents | Not yet recruiting | No Results Available | Aggression|Conduct Disorder | Behavioral: Real-time fMRI feedback|Behavioral: Treatment as usual | https://ClinicalTrials.gov/show/NCT02563145 |
2 | 2 | Carbon Dioxide Insufflation Colonoscopy in IBD Patients | Not yet recruiting | No Results Available | Colonoscopy|Carbon Dioxide|Inflammatory Bowel Disease | Procedure: Carbon dioxide insufflation | https://ClinicalTrials.gov/show/NCT02563132 |
3 | 3 | Intestinal Microbiota in Patients Before and After Bariatric Surgery and Healthy Controls | Completed | No Results Available | Obesity | Procedure: Gastric Bypass or Sleeve gastrectomy | https://ClinicalTrials.gov/show/NCT02563119 |
4 | 4 | A Study of SYN-004 for the Prevention of C.Diff in Patients With a LRTI | Not yet recruiting | No Results Available | Clostridium Difficile|Clostridium Infections | Drug: SYN-004|Drug: Placebo | https://ClinicalTrials.gov/show/NCT02563106 |
5 | 5 | Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults | Recruiting | No Results Available | Influenza | Biological: Fluzone Quadrivalent vaccine, 2015-2016 formulation, No Preservative|Biological: Fluzone Intradermal Quadrivalent vaccine, 2015-2016 formulation|Biological: Fluzone High Dose vaccine, 2015-2016 formulation|Biological: Fluzone High Dose vaccine, 2015-2016 formulation | https://ClinicalTrials.gov/show/NCT02563093 |
6 | 6 | Pancreatic Exocrine Insufficiency in Acute Pancreatitis | Not yet recruiting | No Results Available | Exocrine Pancreatic Insufficiency|Acute Pancreatitis | | https://ClinicalTrials.gov/show/NCT02563080 |
7 | 7 | Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment. | Not yet recruiting | No Results Available | Asthma | Drug: QAW039|Drug: QAW039|Drug: Placebo | https://ClinicalTrials.gov/show/NCT02563067 |
8 | 8 | A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer | Completed | No Results Available | Gastric Cancer | Drug: 5-Fluorouracil|Drug: Capecitabine|Drug: Cisplatin | https://ClinicalTrials.gov/show/NCT02563054 |
9 | 9 | Comparative Effectiveness of 30%TSC and Heparin Lock Solution in Hemodialysis Catheters | Completed | No Results Available | Catheter Related Infection | Drug: 30% TSC|Drug: Heparin | https://ClinicalTrials.gov/show/NCT02563041 |
10 | 10 | A Novel Method for Capturing the Visual Evoked Potential During Microdiscectomy Under Total Intravenous Anesthesia | Not yet recruiting | No Results Available | Evoked Potentials, Visual | Device: SightSaver Visual Stimulator | https://ClinicalTrials.gov/show/NCT02563028 |
11 | 11 | Can Correction of Low Vitamin D Status in Infancy Program for a Leaner Body Composition? | Not yet recruiting | No Results Available | Healthy|Vitamin D Deficiency | Dietary Supplement: cholecalciferol | https://ClinicalTrials.gov/show/NCT02563015 |
12 | 12 | Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177) | Not yet recruiting | No Results Available | Colorectal Carcinoma | Drug: mFOLFOX6|Drug: FOLFIRI|Biological: pembrolizumab|Biological: bevacizumab|Biological: cetuximab | https://ClinicalTrials.gov/show/NCT02563002 |
13 | 13 | [18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001) | Not yet recruiting | No Results Available | Alzheimer's Disease|Amnestic Mild Cognitive Impairment | Drug: [18F]MK-6240|Drug: [18F]MK-6240 | https://ClinicalTrials.gov/show/NCT02562989 |
14 | 14 | OLGA Stage is More Appropriate in Predicting Early Gastric Cancer | Completed | No Results Available | Early Gastric Cancer | Other: gastric atrophy and intestinal metaplasia | https://ClinicalTrials.gov/show/NCT02562976 |
15 | 15 | Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor | Not yet recruiting | No Results Available | Non-small Cell Lung Cancer|Gastric Cancer|Hepatocellular Carcinoma|Colorectal Cancer | Biological: natural killer T cell | https://ClinicalTrials.gov/show/NCT02562963 |
16 | 16 | A Phase I, Open Interaction Study Between GLPG1837 and Midazolam in Healthy Male Subjects | Active, not recruiting | No Results Available | Healthy | Drug: GLPG1837 500 mg|Drug: Midazolam|Drug: GLPG1837 1000 mg | https://ClinicalTrials.gov/show/NCT02562950 |
17 | 17 | Reducing Sedentary Behaviour in University Students Using Text Messages | Completed | No Results Available | Sedentary Lifestyle | Behavioral: text messages related to sedentary behaviour | https://ClinicalTrials.gov/show/NCT02562937 |
18 | 18 | The Efficacy of MEDIHONEY® for Chronic Rhinosinusitis With Nasal Polyposis After Functional Endoscopic Sinus Surgery | Not yet recruiting | No Results Available | Chronic Sinusitis|Nasal Polyposis | Device: MEDIHONEY®|Drug: Budesonide|Drug: Normal saline sinus rinse|Drug: Prednisone|Procedure: Endoscopic sinus surgery|Drug: nasal saline spray | https://ClinicalTrials.gov/show/NCT02562924 |
19 | 19 | Puberty in Girls Followed for Cystic Fibrosis | Recruiting | No Results Available | Cystic Fibrosis | Procedure: Data collection | https://ClinicalTrials.gov/show/NCT02562911 |
20 | 20 | Ibrutinib Combined With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer | Not yet recruiting | No Results Available | Metastatic Pancreatic Adenocarcinoma | Drug: Ibrutinib|Drug: Paclitaxel|Drug: Gemcitabine | https://ClinicalTrials.gov/show/NCT02562898 |
21 | 21 | Effect of Auditory Stimulation on Spike Waves in Sleep | Not yet recruiting | No Results Available | Epilepsy|Sleep | Device: Acoustic pulses | https://ClinicalTrials.gov/show/NCT02562885 |
22 | 22 | DSM265 Prophylaxis of Plasmodium Falciparum Malaria | Not yet recruiting | No Results Available | Healthy | Drug: DSM265|Drug: Placebo|Biological: Sporozoites|Biological: Infective mosquito bite | https://ClinicalTrials.gov/show/NCT02562872 |
23 | 23 | Oral Bioavailability of Solid Formulation of GLPG1837 With and Without Food | Active, not recruiting | No Results Available | Healthy | Drug: 500 mg GLPG1837 as oral suspension|Drug: 500 mg GLPG1837 as oral tablet | https://ClinicalTrials.gov/show/NCT02562859 |
24 | 24 | PRediction Of Treatment Response to ECT in Depression and Cognitive Side effecTs | Recruiting | No Results Available | Depression | Other: Psychological testing and biological sample collection | https://ClinicalTrials.gov/show/NCT02562846 |
25 | 25 | The PLE²NO Self-management and Exercise Program for Knee Osteoarthritis | Completed | No Results Available | Osteoarthritis | Device: Self-Management and exercise|Device: Educational | https://ClinicalTrials.gov/show/NCT02562833 |
26 | 26 | RETT Syndrome: An Exploratory Trial | Not yet recruiting | No Results Available | Rett Syndrome | Procedure: Intravenous infusion|Procedure: Intravenous infusion | https://ClinicalTrials.gov/show/NCT02562820 |
27 | 27 | A Study of TAS-303 in Female Patients With Stress Urinary Incontinence | Not yet recruiting | No Results Available | Stress Urinary Incontinence | Drug: TAS-303 18mg single-dose|Drug: Placebo 18mg single-dose|Drug: TAS-303 9mg single-dose|Drug: Placebo 9mg single-dose | https://ClinicalTrials.gov/show/NCT02562807 |
28 | 28 | Addressing Mental Health Disparities in Refugee Children: A Community-based Participatory Research (CBPR) Collaboration | Not yet recruiting | No Results Available | Child/Adolescent Problems|Mental Disorders | Behavioral: Family Strengthening Intervention-Refugees | https://ClinicalTrials.gov/show/NCT02562794 |
29 | 29 | Is Peri-operative Hyperoxemia a Risk Factor for Postoperative Complications? | Recruiting | No Results Available | Vascular Disease | Drug: Oxygen|Other: Air | https://ClinicalTrials.gov/show/NCT02562781 |
30 | 30 | A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease | Not yet recruiting | No Results Available | Parkinson's Disease | Drug: LY3154207|Drug: Placebo | https://ClinicalTrials.gov/show/NCT02562768 |